Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An esophageal carcinoma characterized by the absence of microscopic features of squamous differentiation. However, there is immunohistochemical evidence of squamous differentiation.
Biomarker and diagnostic research for undifferentiated carcinoma of esophagus has been reported in the published literature.
1 clinical trial registered. Interventions under study include procedural interventions and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
201 publications have been identified in PubMed for undifferentiated carcinoma of esophagus. Kisho has analyzed 148 by research type. Research spans Clinical Trial Publication (36%), Review / Meta-Analysis (29%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 53 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:40 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
36%
Research summaries | 43 | 29% |
Laboratory research | 18 | 12% |
Disease patterns and progression | 15 | 10% |
Testing and diagnosis research | 9 | 6% |
Patient case studies | 5 | 3% |
New treatment approaches | 3 | 2% |
Other research | 2 | 1% |
Kusano C (2026). [PMID: 41032470](https://pubmed.ncbi.nlm.nih.gov/41032470/). *Digestion*. [Review / Meta-Analysis]
Peng Z (2026). [PMID: 41819560](https://pubmed.ncbi.nlm.nih.gov/41819560/). *BMJ*. [Clinical Trial Publication]
Asano N (2026). [PMID: 40952946](https://pubmed.ncbi.nlm.nih.gov/40952946/). *Digestion*. [Review / Meta-Analysis]
Perananthan V (2026). [PMID: 41260764](https://pubmed.ncbi.nlm.nih.gov/41260764/). *Gastrointest Endosc Clin N Am*. [Review / Meta-Analysis]
Janjigian YY (2026). [PMID: 41687718](https://pubmed.ncbi.nlm.nih.gov/41687718/). *Ann Oncol*. [Clinical Trial Publication]
McClurg DP (2026). [PMID: 41219393](https://pubmed.ncbi.nlm.nih.gov/41219393/). *Nat Rev Clin Oncol*. [Review / Meta-Analysis]
Keam SJ (2026). [PMID: 41862758](https://pubmed.ncbi.nlm.nih.gov/41862758/). *Drugs*. [Review / Meta-Analysis]
Fitzgerald RC (2026). [PMID: 42054681](https://pubmed.ncbi.nlm.nih.gov/42054681/). *N Engl J Med*. [Review / Meta-Analysis]
Lee KW (2026). [PMID: 41324998](https://pubmed.ncbi.nlm.nih.gov/41324998/). *Clin Cancer Res*. [Clinical Trial Publication]
Phan E (2026). [PMID: 41392329](https://pubmed.ncbi.nlm.nih.gov/41392329/). *J Gastroenterol Hepatol*. [Review / Meta-Analysis]